DOI:
10.1055/s-00035026
Applied Clinical Informatics
LinksClose Window
References
Ali AK, Hartzema AG.
Assessing the association between omalizumab and arteriothrombotic events through spontaneous adverse event reporting.
Journal of Asthma and Allergy 2012;
5: 1-9.
We do not assume any responsibility for the contents of the web pages of other providers.